Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanai Health Industry Group CoHKSE:01889 40 Median PS Value is HK$1.21 as of Jul. 14, 2026, which is 100% below its 10-year median of 1.59. GuruFocus rates HKSE:01889 with a GF Score™ of 40/100 and a GF Value™ of HK$0.42 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 544 Drug Manufacturers companies, Sanai Health Industry Group Co ranks better than 97.79% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Sanai Health Industry Group Co's Median PS Value or its related term are showing as below:
HKSE:01889'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.16 Med: 1.59 Max: 11.61
Current: 0.16
During the past 13 years, the highest Price to Median PS Value of Sanai Health Industry Group Co was 11.61. The lowest was 0.16. And the median was 1.59.
HKSE:01889's Price-to-Median-PS-Value is ranked better than 97.79% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.87
vs HKSE:01889: 0.16
Sanai Health Industry Group Co (HKSE:01889) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sanai Health Industry Group Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.194
/
1.21
=
0.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co Median PS Value Related Terms
Sanai Health Industry Group Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co Median PS Value Chart
HKSE:01889 vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanai Health Industry Group Co Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sanai Health Industry Group Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.9611.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.617.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co (HKSE:01889) has a Median PS Value of HK$1.21 as of Jul. 14, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sanai Health Industry Group Co and its competitors. This is 24% below median its historical median of 1.59. Over the past decade, Sanai Health Industry Group Co's Median PS Value has ranged from 0.16 to 11.61. According to the industry distribution chart, Sanai Health Industry Group Co ranks #12 out of 544 companies in the Drug Manufacturers industry, placing it in the top 2.2%.
Is Sanai Health Industry Group Co's Median PS Value too high?
Sanai Health Industry Group Co's current Median PS Value of HK$1.21 is 24% below median its 10-year median of 1.59. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 11.61. Based on the distribution chart, Sanai Health Industry Group Co ranks #12 out of 544 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sanai Health Industry Group Co ranks #12 out of 544 companies for Median PS Value. This places Sanai Health Industry Group Co in the top 2% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.87. Historically, Sanai Health Industry Group Co's own Median PS Value has ranged from 0.16 to 11.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.87, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sanai Health Industry Group Co and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanai Health Industry Group Co's current Median PS Value is HK$1.21, which is 24% below median its own 10-year median of 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sanai Health Industry Group Co (HKSE:01889) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.42, compared to a current price of HK$0.19 — trading 53.8% below its estimated fair value. The current Median PS Value is HK$1.21, which is 24% below median its 10-year median of 1.59. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Sanai Health Industry Group Co (HKSE:01889), the current Median PS Value is HK$1.21 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanai Health Industry Group Co (HKSE:01889) Overvalued in 2026?
Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued.
The current stock price of HK$0.19 is trading 53.8% below its estimated GF Value™ of HK$0.42.
GuruFocus considers Sanai Health Industry Group Co to be Possible Value Trap.
Key valuation signals for HKSE:01889:
Median PS Value: HK$1.21 (24% below median its 10-year median of 1.59)
GF Value™: HK$0.42 vs. price of HK$0.19 (53.8% below fair value)
No single metric tells the full story. See the HKSE:01889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanai Health Industry Group Co Business Description
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score
Get the complete analysis for HKSE:01889
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01889 has been successfully added to your 
